山本 晴, モハメド・エルバダウィー, 佐藤 よもぎ, 松井 里穂, 魚本 涼加, 小林 美央, 吉田 敏則, 渋谷 淳, 小林 哲也, 井上 舞, et al. 猫乳腺腫瘍オルガノイドを用いた遺伝子解析による新規治療ターゲットの探索(Exploration of new therapeutic targets using feline mammary tumor organoids). 日本癌学会総会記事. 2023. 82回. 2120-2120
Yomogi Shiota (Sato), Mohamed Elbadawy, Kazuhiko Suzuki, Ryouichi Tsunedomi, Hiroaki Nagano, Yusuke Ishihara, Haru Yamamoto, Daigo Azakami, Tsuyoshi Uchide, Ryuji Fukushima, et al. Derivation of a new model of lung adenocarcinoma using canine lung cancer organoids for translational research in pulmonary medicine. Biomedicine & Pharmacotherapy. 2023. 165. 115079-115079
Tsuyoshi TAJIMA, Masumi SAIGA, Haru YAMAMOTO, Mohamed ELBADAWY, Amira ABUGOMAA, Ryotaro MIURA, Tatsuya USUI, Kazuaki SASAKI, Minoru SHIMODA. Oral pharmacokinetics of sulfadiazine and sulfamonomethoxine in female Holstein milking cows. Journal of Veterinary Medical Science. 2023. 85. 7. 715-720
Yomogi Sato, Mohamed Elbadawy, Kazuhiko Suzuki, Ryouichi Tsunedomi, Hiroaki Nagano, Yusuke Ishihara, Haru Yamamoto, Daigo Azakami, Tsuyoshi Uchide, Rina Nabeta, et al. Establishment of an experimental model of canine malignant mesothelioma organoid culture using a three-dimensional culture method. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023. 162. 114651-114651
Mohamed Elbadawy, Kiwamu Tanabe, Haru Yamamoto, Yusuke Ishihara, Maria Mochizuki, Amira Abugomaa, Hideyuki Yamawaki, Masahiro Kaneda, Tatsuya Usui, Kazuaki Sasaki. Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids. Frontiers in pharmacology. 2023. 14. 1243258-1243258